The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.25
Bid: 27.10
Ask: 27.20
Change: 0.00 (0.00%)
Spread: 0.10 (0.369%)
Open: 27.00
High: 27.25
Low: 27.00
Prev. Close: 27.25
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disclosure of 2020/21 LTIP performance targets

30 Sep 2021 10:43

RNS Number : 5520N
Marston's PLC
30 September 2021
 

30 September 2021

 

Disclosure of LTIP 2020/21 performance targets

 

In the 2020 Annual Report on Remuneration, contained with the Annual Report and Accounts for the 53-week period ending 3 October 2020, the Remuneration Committee confirmed that in light of the continuing global pandemic and the impact on economic conditions, setting appropriate targets was challenging and the Committee had agreed to delay the grant of options for the 2020/21 LTIP award until later in the financial period. The Company announced on 25 May 2021 that awards had been granted and today announces that performance targets have now been confirmed.

 

Vesting of these awards will be determined in accordance with the following performance targets measured over the three financial periods ending 30 September 2023.

 

Performance measure

Weighting

Threshold (25% vesting)

On-target (50% vesting)

Maximum (100% vesting)

Underlying EPS

40%

6.4p

6.9p

7.2p

Net Cash Flow

40%

£200m

£215m

£240m

TSR v FTSE250 (excluding Investment Trusts)

20%

Median

-

Upper quartile

 

Underlying EPS excludes income from associates.

 

The Remuneration Committee reserves the right to adjust the Net Cash Flow targets (up or down) in the event the contingent proceeds from the disposal of the Beer Company materially differ from the assumptions made when the targets were agreed. Any adjustment will be disclosed in the Directors' Remuneration Report.

 

 

To the extent an award vests, it will be released (so that the participant is entitled to acquire the shares) following the end of a further two year holding period.

 

 

 

 

 

Enquiries:

Anne-Marie Brennan, Group Secretary, Marston's PLC, +44 (0) 1902 329163

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANNEDLAFEEA
Date   Source Headline
2nd Jul 20182:48 pmRNSTotal Voting Rights
2nd Jul 20189:27 amRNSDirector/PDMR Shareholding
21st Jun 20189:57 amRNSHolding(s) in Company
19th Jun 20183:21 pmRNSDirector/PDMR Shareholding
19th Jun 201811:07 amRNSHolding(s) in Company
12th Jun 201810:13 amRNSDirector/PDMR Shareholding
6th Jun 20181:18 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSStatement re analyst site visit
23rd May 201812:09 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSInterim Results for 26 weeks ended 31 March 2018
11th May 201812:38 pmRNSAppointment of Interim Chairman
16th Apr 20189:51 amRNSHolding(s) in Company
3rd Apr 201811:01 amRNSTotal Voting Rights
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSAppointment of Chairman
21st Feb 20184:01 pmRNSHolding(s) in Company
6th Feb 20182:12 pmRNSDirector/PDMR Shareholding
24th Jan 20189:53 amRNSResult of AGM
23rd Jan 20187:00 amRNSTrading update for the 16 weeks to 20 January 2018
10th Jan 201810:07 amRNSBlock listing Interim Review
2nd Jan 20183:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20182:25 pmRNSTotal Voting Rights
20th Dec 20179:42 amRNSDirector Declaration
20th Dec 20177:00 amRNSWilliam Hill appoints Chairman Designate
18th Dec 20174:27 pmRNSAnnual Financial Report
12th Dec 20174:27 pmRNSDirector/PDMR Shareholding
12th Dec 20174:25 pmRNSDirector/PDMR Shareholding
5th Dec 20172:02 pmRNSDirector/PDMR Shareholding
1st Dec 201711:44 amRNSTotal Voting Rights
30th Nov 20177:00 amRNSPreliminary Results
27th Nov 20177:00 amRNSDirectorate
1st Nov 20171:17 pmRNSTotal Voting Rights
10th Oct 20177:00 amRNSYear-End Trading Update
2nd Oct 20172:48 pmRNSTotal Voting Rights
29th Sep 201710:27 amRNSDirector/PDMR Shareholding
8th Sep 20172:20 pmRNSDirector/PDMR Shareholding
5th Sep 201711:55 amRNSDirectorate Change
1st Sep 20171:47 pmRNSTotal Voting Rights
26th Jul 20177:00 amRNSTrading Update
11th Jul 20178:41 amRNSBlock listing Interim Review
5th Jul 20174:18 pmRNSDirector/PDMR Shareholding
4th Jul 20179:04 amRNSDirector/PDMR Shareholding
28th Jun 20174:03 pmRNSDirector/PDMR Shareholding
22nd Jun 20173:06 pmRNSDirector/PDMR Shareholding
20th Jun 20172:13 pmRNSDirector/PDMR Shareholding
20th Jun 20177:01 amRNSDirector Declaration
2nd Jun 20174:45 pmRNSCompletion of Acquisition of Charles Wells
25th May 20173:12 pmRNSHolding(s) in Company
22nd May 20173:19 pmRNSTotal Voting Rights
18th May 20172:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.